Omixon is Now ISO Certified for Canada

26/03/2018

Omixon announce its Quality Management System complies with the requirements of ISO 13485:2003 certified by a CMDCAS recognised registrar. As a result Omixon’s QMS meets the Canadian Medical Devices Regulations for design, development, manufacture and distribution, servicing and customer support of In Vitro diagnostic reagents, kits and software...

Omixon Educative Series: HLA – Basic Immunological Roles

16/03/2018

Learn more about the role of the human leukocyte antigen (HLA) system in and beyond transplantation! Please find the first part of our HLA Educative Series that targets a wide range of knowledge levels. We start with their basic immunology that will be followed by their roles in transplantation,...

HLA Market Directions – Interview with Marcello Scala, Vice President for Sales EMEA and Asia

01/03/2018

As NGS continues to be adopted across the world, we are delighted to announce the latest expansion of Holotype HLA to Portugal and the Middle East. In an interview with Marcello Scala, our Vice President for Sales in EMEA and Asia, we discussed how the market is changing and...

Sign Up Today! HLA Twin Live Software Demos at EFI 2018

22/02/2018

Join our crew at the Omixon booth to familiarize yourself with our HLA Twin genotyping software during the EFI Conference in Venice! Our software demos were incredibly successful during the ASHI Meeting last year, so we extended the duration from 20 to 30 minutes. The demos are designed to...

One Donor Can Save Eight Lives

14/02/2018

You, or anyone you know would need to have an organ transplant, would be one out of those 116,000 individuals from the US national transplant waiting list. In fact, 10 people are added to the list in every single minute. Despite improvements in the organ registration systems and in...